Skip to main content
Jeffrey R. Jacobsen

Jeffrey R. Jacobsen, MD

Languages spoken: English
  • Specialties

    • Pathology, Clinical

    Board Certification

    American Board of Pathology (Anatomic & Clinical)
    American Board of Pathology (Sub: Hematopathology)
  • Board Certification and Academic Information

    Academic Departments Pathology -Primary
    Board Certification
    American Board of Pathology (Anatomic & Clinical)
    American Board of Pathology (Sub: Hematopathology)

    Education history

    Fellowship Hematopathology - University of Utah School of Medicine Fellow
    Anatomic & Clinical Pathology - University of Utah School of Medicine Resident
    Professional Medical Medicine - University of Illinois College of Medicine M.D.
    Biochemistry - Southern Illinois University B.A.

    Selected Publications

    Journal Article

    1. Bapat A, Keita N, Martelly W, Kang P, Seet C, Jacobsen JR, Stoilov P, Hu C, Crooks GM, Sharma S (2018). Myeloid Disease Mutations of Splicing Factor SRSF2 Cause G2-M Arrest and Skewed Differentiation of Human Hematopoietic Stem and Progenitor Cells. Stem Cells, 36(11), 1663-1675. (Read full article)
    2. Szewc AM, Taylor S, Cage GD, Jacobsen J, Bulut OP, de Mello DE (2018). Acute Liver Failure in an Adolescent Male Induced by Human Herpesvirus 6 (HHV-6): A Case Report With Literature Review. Lab Med, 49(2), 165-174. (Read full article)
    3. Lussier DM, ONeill L, Nieves LM, McAfee MS, Holechek SA, Collins AW, Dickman P, Jacobsen J, Hingorani P, Blattman JN (2015). Enhanced T-cell immunity to osteosarcoma through antibody blockade of PD-1/PD-L1 interactions. J Immunother, 38(3), 96-106. (Read full article)
    4. Srinivasan A, Panetta JC, Cross SJ, Pillai A, Triplett BM, Shook DR, Dallas MH, Hartford C, Sunkara A, Kang G, Jacobsen J, Choi J, Leung W (2014). Phase I study of the safety and pharmacokinetics of plerixafor in children undergoing a second allogeneic hematopoietic stem cell transplantation for relapsed or refractory leukemia. Biol Blood Marrow Transplant, 20(8), 1224-8. (Read full article)
    5. Jeha S, Coustan-Smith E, Pei D, Sandlund JT, Rubnitz JE, Howard SC, Inaba H, Bhojwani D, Metzger ML, Cheng C, Choi JK, Jacobsen J, Shurtleff SA, Raimondi S, Ribeiro RC, Pui CH, Campana D (2014). Impact of tyrosine kinase inhibitors on minimal residual disease and outcome in childhood Philadelphia chromosome-positive acute lymphoblastic leukemia. Cancer, 120(10), 1514-9. (Read full article)
    6. Abraham S, Salama M, Hancock J, Jacobsen J, Fluchel M (2012). Congenital and childhood myeloproliferative disorders with eosinophilia responsive to imatinib. Pediatr Blood Cancer, 59(5), 928-9. (Read full article)
    7. Patel JL, Smith LM, Anderson J, Abromowitch M, Campana D, Jacobsen J, Lones MA, Gross TG, Cairo MS, Perkins SL (2012). The immunophenotype of T-lymphoblastic lymphoma in children and adolescents: a Children's Oncology Group report. Br J Haematol, 159(4), 454-61. (Read full article)
    8. Inaba H, Coustan-Smith E, Cao X, Pounds SB, Shurtleff SA, Wang KY, Raimondi SC, Onciu M, Jacobsen J, Ribeiro RC, Dahl GV, Bowman WP, Taub JW, Degar B, Leung W, Downing JR, Pui CH, Rubnitz JE, Campana D (2012). Comparative analysis of different approaches to measure treatment response in acute myeloid leukemia. J Clin Oncol, 30(29), 3625-32. (Read full article)
    9. Clifford SM, Bunker AM, Jacobsen JR, Roberts WL (2011). Age and gender specific pediatric reference intervals for aldolase, amylase, ceruloplasmin, creatine kinase, pancreatic amylase, prealbumin, and uric acid. Clin Chim Acta, 412(9-10), 788-90. (Read full article)


    1. Freeman CM, Wright BL, Bauer CS, Rukasin CR, Chiang SC, Marsh RA, Taylor S, Jacobsen J, Miller HK, Badia P (2021). Cutaneous T-cell lymphoma as a unique presenting malignancy in X-linked magnesium defect with EBV infection and neoplasia (XMEN) disease. [Letter to the editor]. Clin Immunol, 226, 108722. (Read full article)
    2. McInnis-Smith K, Mansueto LA, Schafernak K, Jacobsen J, Henry MM, Ramasubramanian A (2020). Isolated optic nerve leukemic relapse diagnosed via fine needle aspiration biopsy and transconjunctival biopsy. [Letter to the editor]. Pediatr Blood Cancer, 68(2), e28684. (Read full article)